• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

ClearPoint Neuro Inc. - Common Stock (NQ:CLPT)

11.16 +0.13 (+1.18%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 17, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 448,972
Open 11.09
Bid (Size) 10.50 (100)
Ask (Size) 10.75 (400)
Prev. Close 11.03
Today's Range 11.00 - 11.34
52wk Range 8.630 - 30.10
Shares Outstanding 23,639,616
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
ClearPoint Neuro (CLPT) Earnings Call Transcript ↗
March 17, 2026
ClearPoint Neuro (CLPT) Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
ClearPoint Neuro Inc (NASDAQ:CLPT) Reports Q4 2025 Revenue Beat Amid Widened Loss, Shares Fall ↗
March 17, 2026
Via Chartmill

Performance

YTD
-20.5%
-20.5%
1 Month
-17.8%
-17.8%
3 Month
-19.2%
-19.2%
6 Month
+4.8%
+4.8%
1 Year
-17.9%
-17.9%

More News

Read More
News headline image
ClearPoint Neuro Reports Fourth Quarter and Full Year 2025 Results
March 17, 2026
Via ACCESS Newswire
News headline image
ClearPoint Neuro to Announce Fourth Quarter and Full Year 2025 Results March 17, 2026
March 06, 2026
Via ACCESS Newswire
Let's uncover which stocks are experiencing notable gaps during today's session. ↗
March 02, 2026
Via Chartmill
Get insights into the top gainers and losers of Monday's pre-market session. ↗
March 02, 2026
Via Chartmill
News headline image
ClearPoint Neuro Announces Preliminary Unaudited Fourth Quarter and Full Year 2025 Revenue
January 12, 2026
Via ACCESS Newswire
News headline image
ClearPoint Neuro Completes Acquisition of IRRAS
November 20, 2025
Via ACCESS Newswire
News headline image
ClearPoint Neuro Reports Third Quarter 2025 Results
November 06, 2025
Via ACCESS Newswire
News headline image
ClearPoint Neuro Announces Agreement to Acquire IRRAS
November 06, 2025
Via ACCESS Newswire
News headline image
ClearPoint Neuro to Participate in Multiple Global Healthcare Conferences in the Fourth Quarter of 2025
November 05, 2025
Via ACCESS Newswire
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
November 03, 2025
Via Benzinga
News headline image
Gapping stocks in Monday's session ↗
November 03, 2025
Via Chartmill
News headline image
Discover the top movers in Monday's pre-market session. ↗
November 03, 2025
Via Chartmill
News headline image
Kimberly-Clark, Vertex And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗
November 03, 2025
Via Benzinga
News headline image
ClearPoint Neuro Shares Are Trading Higher Wednesday: What's Going On? ↗
October 08, 2025
Via Benzinga
News headline image
ClearPoint Neuro Announces Promising Results from Brain Tumor Laser Therapy Study to be Presented at the CNS Annual Meeting in Los Angeles
October 07, 2025
Via ACCESS Newswire
News headline image
ClearPoint Neuro Announces Expanded International Clearances for Key Therapy Delivery Product; Now Totaling 34 Countries Worldwide
October 06, 2025
Via ACCESS Newswire
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
October 03, 2025
Via Benzinga
News headline image
ClearPoint Neuro Announces Development and Demonstration of the Company's Proprietary Robotic Neuro-Navigation System
October 01, 2025
Via ACCESS Newswire
News headline image
ClearPoint Neuro Announces the Appointment of Dr. Paul Larson as Chief Medical Officer
September 25, 2025
Via ACCESS Newswire
News headline image
Why PepGen Shares Are Trading Higher By 112%; Here Are 20 Stocks Moving Premarket ↗
September 25, 2025
Via Benzinga
News headline image
Top movers in Wednesday's session ↗
September 24, 2025
Via Chartmill
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
September 24, 2025
Via Benzinga
News headline image
Keep an eye on the top gainers and losers in Wednesday's session. ↗
September 24, 2025
Via Chartmill

Frequently Asked Questions

Is ClearPoint Neuro Inc. - Common Stock publicly traded?
Yes, ClearPoint Neuro Inc. - Common Stock is publicly traded.
What exchange does ClearPoint Neuro Inc. - Common Stock trade on?
ClearPoint Neuro Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for ClearPoint Neuro Inc. - Common Stock?
The ticker symbol for ClearPoint Neuro Inc. - Common Stock is CLPT on the Nasdaq Stock Market
What is the current price of ClearPoint Neuro Inc. - Common Stock?
The current price of ClearPoint Neuro Inc. - Common Stock is 11.16
When was ClearPoint Neuro Inc. - Common Stock last traded?
The last trade of ClearPoint Neuro Inc. - Common Stock was at 03/17/26 04:00 PM ET
What is the market capitalization of ClearPoint Neuro Inc. - Common Stock?
The market capitalization of ClearPoint Neuro Inc. - Common Stock is 263.82M
How many shares of ClearPoint Neuro Inc. - Common Stock are outstanding?
ClearPoint Neuro Inc. - Common Stock has 264M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap